The normal population distribution of PRNP codon 129 polymorphism

Acta Neurologica Scandinavica

Volumn 108, Issue 5, 2003, Pages 374-378

  Nurmi, M H ^a   Bishop, M ^b   Strain, L ^c   Brett, F ^d   McGuigan, C ^d   Hutchison, M ^d   Farrell, M ^d   Tilvis, R ^e   Erkkila S ^f   Simell, O ^f   Knight, R ^b   Haltia, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c INSTITUTE OF HUMAN GENETICS   (United Kingdom)

^d BEAUMONT HOSPITAL   (Ireland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

Creutzfeldt Jakob disease; Prion diseases; PRNP codon 129; PRNP polymorphism

Indexed keywords

METHIONINE; PRION PROTEIN; VALINE;

AGED; ALLELE; ARTICLE; BLOOD DONOR; CODON; DISEASE PREDISPOSITION; FEMALE; FINLAND; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRELAND; MALE; PHENOTYPE; PRION DISEASE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AMYLOID; CODON; FEMALE; FINLAND; GREAT BRITAIN; HUMANS; INFANT, NEWBORN; IRELAND; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PRIONS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REFERENCE VALUES;

EID: 10744219606     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00199.x     Document Type: Article

References (32)

1. PRUSINER SB. Molecular biology and pathogenesis of prion disease. Trends Biol Sci 1996;21:482-7.
2. JOHNSON RT, GIBBS CJ, JR. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:1994-2004.
3. GAMBETTI P, PETERSEN RB, PARCHI P et al. Inherited prion diseases. In: Prusiner SB, ed. Prion biology and diseases. Cold Spring Harbor, NY: Cold Springs Harbor Laboratory Press, 1999;509-83.
4. PALMER MS, DRYDEN AJ, HUGHES JT, COLLINGE J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991;325:340-2.
5. VALLERON AJ, BOELLE PY, WILL R, CESBRON JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001; 294:1726-8.
6. PARCHI P, GIESE A, CAPELLARI S et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33.
7. GOLDFARB LG, PETERSEN RB, TABATON M et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by DNA polymorphism. Science 1992;258:806-8.
8. ALPEROVITCH A, ZERR I, POCCHIARI M et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999;353:1673-4.
9. Data collected by the UK Creutzfeldt-Jakob Disease Surveillance Unit are available at http://www.cjd.ed.ac.uk/.
10. WILL RG, ALPEROVITCH A, POSER S et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. Ann Neurol 1998;43:763-7.
11. LOUHIJA J, MIETTINEN HE, KONTULA K, TIKKANEN MJ, MIETTINEN TA, TILVIS RS. Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler Thromb 1994;14: 1084-9.
12. PLAITAKIS A, VISKADOURAKI AK, TZAGOURNISSAKIS M et al. Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate of PRNP 129-methionine homozygosity in the local population. Ann Neurol 2001;50:227-33.
13. BRATOSIEWICZ J, KORDEK R, KULCZYCKI J, BOTTS G, LIBERSKI PP. Molecular analysis of PRNP gene in Polish population and in Creutzfeldt-Jakob disease. Folia Neuropathol 1999;37:277-80.
14. BROWN P, CERVENAKOVA L, GOLDFARB LG et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 1994;44:291-3.
15. COLLINGE J, PALMER MS, DRYDEN AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337:1441-2.
16. COMBARROS O, SANCHEZ-UUERRA M, LLORCA J et al. Polymorphism at codon 129 of the prion protein gene is not associated with sporadic AD. Neurology 2000;55:593-5.
17. DESLYS JP, MARCE D, DORMOND D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol 1994;75:23-7.
18. DOH-URA K, KITAMOTO T, SAKAKI Y, TATEISHI J. CJD discrepancy. Nature 1991;358:801-2.
19. ERGINEL-UNALTUNA N, PEOC'H K, KOMURCU E, ACUNER TT, ISSEVER H, LAPLANCHE JL. Distribution of the M129V polymorphism of the prion protein gene in a Turkish population suggests a high risk for Creutzfeldt-Jakob disease. Eur J Hum Genet 2001;9:965-8.
20. LAPLANCHE JL, DELASNERIE-LAUPRETRE N, BRANDEL JP et al. Molecular genetics of prion disease in France. Neurology 1994;44:2347-51.
21. MEDORI R, TRITSCHLER HJ. Prion protein gene analysis in three kindreds with fatal familial insomnia (FFI): codon 178 mutation and codon 129 polymorphism. Am J Hum Genet 1994;53:822-7.
22. SALVATORE M, GENUARDI M, PETRAROLI R, MASULLO C, D'ALESSANDRO M, POCCHIARI M. Polymorphism of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease. Hum Genet 1994;94:375-9.
23. TSAI MT, SU YC, CHEN YH, CHEN CH. Lack of evidence to support the association of the human prion gene with schizophrenia. Mol Psychiatry 2001;6:74-8.
24. ZIMMERMANN K, TURECEK PL, SCHWARZ HP. Genotyping of the prion protein gene at codon 129. Acta Neuropathol 1999;97:355-8.
25. http://www.veripalvelu.redcross.fi
26. CAVALLI-SFORZA L, MENOZZI P, PIAZZA A. The history and geography of human genes. Princeton: Princeton University Press, 1994;225-54.
27. NAKAMURA Y, YANAGAWA H, HOSHI K, YOSHINO H, URATA J, SATO T. Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol 1999;28:130-4.
28. MEAD S, STUMPF MP, WHITfIELD J et al. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 2003;300:640-3.
29. SHIBUYA S, HIGUCHI J, SHIN RW, TATEISHI J, KITAMOTO T. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:826-8.
30. D'AIGNAUX JN, COUSENS SN, SMITH PG. Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science 2001;294:1729-31.
31. FERGUSON NM, GHANI AC, DONNELLY CA, HAGENAARS TJ, ANDERSON RM. Estimating the human health risk from possible BSE infection of British sheep flock. Nature 2002;415:420-4.
32. LEE HS, BROWN P, CERVENAKOVA L et al. Increased susceptibility to kuru of the PRNP 129 methionine/methionine genotype. J Infect Dis 2001;183:192-6.